# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
JP Morgan analyst Sebastian Sandler maintains Adaptive Biotechnologies (NASDAQ:ADPT) with a Overweight and raises the price ...
Guggenheim analyst Subbu Nambi initiates coverage on Adaptive Biotechnologies (NASDAQ:ADPT) with a Buy rating and announces ...
JP Morgan analyst Rachel Vatnsdal maintains Adaptive Biotechnologies (NASDAQ:ADPT) with a Overweight and raises the price ta...
TD Cowen analyst Dan Brennan maintains Adaptive Biotechnologies (NASDAQ:ADPT) with a Buy and raises the price target from $1...
Piper Sandler analyst David Westenberg maintains Adaptive Biotechnologies (NASDAQ:ADPT) with a Overweight and raises the pri...